HC Wainwright reaffirmed their buy rating on shares of Altimmune (NASDAQ:ALT – Free Report) in a research report sent to ...
Cytokinetics (NASDAQ:CYTK – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a research note issued to investors on Friday,Benzinga reports. They currently have a $120.00 ...
In a report released on April 4, Doron Lande from Kepler Capital maintained a Buy rating on COMET Holding AG (COTN – Research Report), with a ...